RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Out-licensing Search

Search the Innovaro Medical Device Licensing out-licensing directory by keyword. Alternatively our advanced search allows you to query by industry sector, therapeutic target and development phase.
 
Industry sector Therapeutic target
Development phase
To choose more then one item on the list hold CTRL button while selecting. To deselect items press CTRL button and deselect.

Most Viewed

New cream formulation to manage the symptoms of atopic dermatitis. More
5 and 10 mg Donepezil as well as 4 and 8 mg Ondansetron are under final development using the proprietary RapidFilm drug delivery Technology securing fast dissolution in the oral cavity without the need of water More
Collagen-based dressings for wound management More
25 and 50 mg diclofenac K film coated immediate release tablets More
Xclair is a cream, indicated for the management of radiation-induced dermatitis, including relief and management of the most common signs and symptoms such as pruritus, erythema, burning and pain. More

Recently Added

It is a patented combination of standardized extracts and is clinically proven (n= 77) to reduce Calculi surface area, pain and to maintain Complete Kidney Health by preventing reoccurrence of stones. More
E-MA-07, a clinically proven formula to address all aspects of Male Sexual Dysfunction (MSD). Phase II Clinical Trials showed good efficacy and can be furthur developed as Botanical Drug Product. More
Medium sized Indian company owns the patent for the preparation of sustained release Trimetazidine Dihydrochloride composition indicated for the treatment of angina and is now looking for out-licensing partners. More
Topical anesthetic for long-term care market More
Medical adhesive available for home care & veterinary market More

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2010 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us